O-1871
| |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C23H38O2 |
Molar mass | 346.55 g/mol |
3D model (JSmol) | |
| |
|
O-1871 is a potent cannabinoid agonist which was invented by Billy R Martin and Raj K Razdan in 2002. It has a CB1 receptor affinity of 2.0nM and a CB2 receptor affinity of 0.3nM.[1] Structurally, O-1871 is a cyclohexylphenol derivative related to CP 47,497,[2] and so is illegal in some jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivative O-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative,[3] which are not cyclohexylphenol derivatives.
See also
References
- ↑ Billy R Martin, Raj K Razdan. CANNABINOIDS. Patent WO 2003/091189
- ↑ Debruyne D, Le Boisselier R. Emerging drugs of abuse: Current perspectives on synthetic cannabinoids. Substance Abuse and Rehabilitation 2015; 6: 113-129. doi:10.2147/SAR.S73586
- ↑ Xin-Zhong Lai, Dai Lu, Alexandros Makriyannis. Novel biphenyl and biphenyl-like cannabinoids. Patent US 2004/0087590
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.